Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pharmaust Limited (AU:PAA)
ASX:PAA
RESEARCH TOOLSreports
Pharmaust Limited (PAA) Share Price & Analysis
4 Followers
PAA Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.07 - AU$0.54
Previous CloseAU$0.32
Volume580.12K
Average Volume (3M)1.57M
Market Cap
AU$126.19M
Enterprise ValueAU$125.16M
Total Cash (Recent Filing)AU$2.42M
Total Debt (Recent Filing)AU$1.39M
Price to Earnings (P/E)-15.7
Beta0.84
Next Earnings
Aug 30, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares OutstandingN/A
10 Day Avg. Volume627,194
30 Day Avg. Volume1,566,309
Standard Deviation0.26
R-Squared0.03
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Pharmaust Limited News
PremiumCompany Announcements
Pharmaust Limited Expands its ASX Securities
PremiumCompany Announcements
PharmAust Advances MND Treatment StudyOptions Prices
Currently, No data available
---
Ownership Overview
25.41% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
74.59% Public Companies and
Individual Investors
PAA FAQ
What was Pharmaust Limited’s price range in the past 12 months?
Pharmaust Limited lowest share price was AU$0.07 and its highest was AU$0.54 in the past 12 months.
What is Pharmaust Limited’s market cap?
Currently, no data Available
When is Pharmaust Limited’s upcoming earnings report date?
Pharmaust Limited’s upcoming earnings report date is Aug 30, 2024 which is in 121 days.
How were Pharmaust Limited’s earnings last quarter?
Pharmaust Limited released its earnings results on Feb 29, 2024. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.
Is Pharmaust Limited overvalued?
According to Wall Street analysts Pharmaust Limited’s price is currently Overvalued.
Does Pharmaust Limited pay dividends?
Pharmaust Limited does not currently pay dividends.
What is Pharmaust Limited’s EPS estimate?
Pharmaust Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pharmaust Limited have?
Pharmaust Limited has 394,331,180 shares outstanding.
What happened to Pharmaust Limited’s price movement after its last earnings report?
Pharmaust Limited reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 7.692%.
Which hedge fund is a major shareholder of Pharmaust Limited?
Currently, no hedge funds are holding shares in AU:PAA
---
Pharmaust Limited Stock Smart Score
Company Description
Pharmaust Limited
PharmAust Ltd operates as a drug discovery and development company in Australia, Switzerland, and internationally. It develops drug discovery intellectual property for the treatment of various cancers in humans and animals. The company offers Monepantel and Albendazole, which are in Phase II clinical trials for the treatment of cancer. It also provides medicinal and synthetic chemistry services on a contract basis to the drug discovery and pharmaceutical industries.
---
Technical Analysis
Pharmaust Limited
―
Mister Spex SE
―
Medical Developments International Limited
―
Bod Australia Ltd
―
IDT Australia Limited
―
---